Blog
Buying supplies

Can a Med Spa Buy Injectables from Canada? What the Law Says

Can a med spa buy injectables from Canada? Understand US import limits, enforcement cases and the supplier checks to make before placing your next order.

On this page

    TL;DR

    • A genuine product still needs a lawful US supply path.
    • Canada importation programs and personal-use policies do not cover stocking your practice with foreign toxins or fillers.
    • Verify both the supplier and the product before using a shipment.

    If a supplier offers injectables from Canada for your med spa, you need to know whether you can legally use them. The US Food and Drug Administration (FDA) says importing unapproved prescription drugs from foreign sources is illegal "in virtually all cases". Here's what that means for your buying decision.

    This guide explains:

    1. Why receiving and using foreign products can break the law
    2. Why genuine product still needs verification
    3. What has happened to practices and practitioners
    4. Which importation programs apply
    5. How to check an authorized US source

    General information, not legal advice. Confirm your state's rules with counsel or your board.

    Can Med Spas Legally Buy Injectables from Canada?

    No med spa may legally buy prescription injectables from Canada outside the lawful US supply chain. Prescription drugs must come from sellers holding the required state or federal license or registration. Outside narrow exceptions, only the manufacturer may re-import a US-made prescription drug that was exported. The law reaches the receiving practice, not just the seller.

    Misbranded means a drug or device fails labeling requirements, such as required directions or warnings.

    Adulterated means a drug or device fails applicable federal standards, such as those for contamination, manufacturing, holding or storage conditions, drug strength, quality or purity, or required approval for certain devices.

    Federal law prohibits receiving misbranded or adulterated drugs or devices in interstate commerce and delivering or offering them to others, paid or not.

    The narrow importation exceptions do not provide a way to stock a med spa with unapproved foreign-market toxins or fillers.

    The penalties depend on what happened:

    • Receiving misbranded drugs and delivering them to others: A violation can carry up to one year in prison, a fine, or both (21 USC 333(a)(1)).
    • Repeating a violation, or intending to defraud or mislead: The maximum rises to three years, a fine, or both. The repeat-offense rule applies after a prior conviction becomes final (Section 333).
    • Knowingly importing a drug in violation of the reimportation and import provision (21 USC 381(d)(1)): Up to 10 years in prison, a fine up to $250,000, or both (21 USC 333(b)(1)).

    Common Myths About Buying Injectables from Canada

    Check these assumptions before accepting a seller's explanation.

    • Myth: Genuine Product Makes It Legal. Authenticity alone does not establish a lawful supply path.
    • Myth: Only the Seller Is Liable. The receiving practice can also violate federal law.
    • Myth: The Canada Rule Covers Toxins. Section 804, the federal Canada importation pathway, excludes biological products, including botulinum toxins.
    • Myth: Small Orders Count as Personal Use. Personal importation excludes further sale or distribution into US commerce.
    • Myth: Fillers Have Looser Rules. Unapproved foreign fillers remain subject to device requirements.

    Is Genuine Foreign-Market Product Legal to Use?

    Not on authenticity alone. Botulinum toxins need an active biologics license for that product. Each package must carry the required identifying information.

    For commercial imports of genuine foreign-manufactured prescription drugs, the manufacturer generally must authorize and label them for the US market.

    Authenticity is one check within that process. Use the guide to spotting fake Botox when inspecting a shipment.

    Have Med Spas Been Prosecuted for Using Foreign Injectables?

    Yes. US Department of Justice (DOJ) reports and a state board order show criminal proceedings, board discipline and a civil settlement. Outcomes depend on the conduct and proceeding.

    • December 2016, Kansas: A physician assistant bought misbranded toxin and adulterated, unapproved filler from Canadian pharmacies without telling clients they came from Canada or failed federal standards. After pleading guilty to receiving and dispensing misbranded drugs, the assistant received one year of federal probation.
    • September 2018, Kansas State Board of Healing Arts disciplinary order: Following a federal misdemeanor conviction, a physician received public censure and a fine for using foreign-sourced toxin from unauthorized distributors. The manufacturer made or marketed the product, and neither party presented evidence of adulteration. The board weighed that the physician knew it was wrong and tried to avoid detection.
    • November 2022, California: Online sellers outside the United States supplied a physician and practice with unapproved toxin drugs and filler devices. For receiving and delivering misbranded drugs and misbranded and adulterated devices, the physician pleaded guilty to a misdemeanor and the practice to a felony. The physician falsely presented them as FDA-approved and concealed the conduct from patients, FDA and the authorized distributor.
    • May 2023, Michigan: A physician and practice agreed to pay $135,871.84 to settle False Claims Act allegations about treating Medicare patients with unapproved foreign-market toxin and billing for those services. The government alleged that officials seized packages en route to the practice. The settlement resolved allegations without a determination of liability.
    • July 2023, Missouri: A med spa owner received two years in federal prison for receiving misbranded drugs and adulterated devices and delivering them for pay with intent to defraud or mislead. The owner falsely claimed nursing qualifications and licensure, concealed unapproved products and continued injections after learning of patient injuries.
    • October 2023, California: A physician received three years of probation, a $201,534 fine and $100,767 forfeiture over unapproved cosmetic drugs smuggled from Mexico. The physician pleaded guilty to two misdemeanors: receipt of misbranded drugs and "Accessory After the Fact to Entry of Goods by Means of False Statement". Many patients were never told they received unapproved drugs.

    What Happened in the Canada Drugs Case?

    Canada Drugs matters to injectable buyers because its supplier network also sold toxin products to US practices. FDA's November 2012 letter described most, if not all, products from those suppliers, including botulinum toxin products, as unapproved.

    The federal case involved counterfeit cancer drugs, with no active ingredient in tested vials. In 2010, FDA learned the company was shipping US providers unapproved drugs with foreign-language labels and inadequate instructions.

    In April 2018, Canada Drugs and associated companies were sentenced to forfeit $29 million, pay a $5 million fine and serve five years of probation.

    Does the 2020 Canada Importation Rule Cover Med Spa Inventory?

    No. The Section 804 eligibility rule excludes biological products, including botulinum toxins. Its prescription-drug scope also excludes filler devices.

    The 2020 rule set up a process for FDA to review and authorize importation programs. States and Indian Tribes can propose programs, with pharmacists and wholesalers able to do so in certain future circumstances.

    Importers must be appropriately licensed pharmacists or wholesale distributors meeting the program conditions. Authority to administer injectables does not itself qualify a practice.

    Can a Practice Use the FDA Personal Importation Policy?

    No. FDA's personal importation policy concerns individual use, not products for further sale or distribution into US commerce. FDA says personal imports of drugs or devices are illegal in most circumstances.

    FDA considers limited situations in which it may allow an individual import. Those considerations concern personal treatment, not a practice's patient inventory, and generally apply to biological products and medical devices too.

    Are Dermal Fillers Subject to the Same Rules as Toxins?

    Fillers are regulated as devices, but that does not make unapproved foreign fillers a lawful option. Receiving adulterated or misbranded filler devices in interstate commerce and delivering them to others violates federal law.

    The Drug Supply Chain Security Act (DSCSA), which governs prescription-drug suppliers and tracing, does not cover devices. For the buying process, see wholesale dermal filler sourcing.

    How to Check That an Injectable Supplier Is Authorized

    Check that your supplier has the required license or registration. FDA's Know Your Source guidance urges you to verify the supplier's state license.

    Federal drug supply law includes people authorized to administer prescription drugs among the buyers called "dispensers". Its supplier requirements include:

    • Wholesaler: Check for a valid license and required licensure reporting.
    • Manufacturer or repackager: Check for valid registration.

    The practitioner exception removes specified tracing and verification duties for licensed practitioners authorized to prescribe or administer medication under state law. It also covers licensed individuals under their supervision or direction. For both groups, the exception applies when dispensing or administering medication in usual professional practice.

    FDA's letter to practices says providers must buy prescription drugs from authorized trading partners: suppliers with the required license or registration.

    Before you accept a shipment:

    1. Supplier: Verify authorization before ordering.
    2. Product: Check the specific product and US-market labeling using Drugs@FDA and Devices@FDA, FDA's public databases for approval or clearance checks.
    3. Paperwork: Keep transaction paperwork, supplier verification, invoices and receiving records.
    4. Delivery: Compare the shipment with your order and inspect its packaging before use.

    FDA flags these product warning signs:

    • Non-English labeling.
    • A missing National Drug Code (NDC) on the label may suggest the prescription drug was not made for the US market and may not meet US requirements. FDA notes that an NDC is not required on the label and does not denote FDA approval.
    • Shipping conditions inconsistent with labeled storage requirements.

    Aggressive marketing and deep discounts may indicate stolen, counterfeit, substandard or unapproved products.

    Also check who can legally buy toxins and wholesale neurotoxin sourcing. For compounding questions, see 503A vs 503B pharmacies.

    What to Do If You Already Have Suspect Product

    Stop using suspect product and ask FDA how to handle your inventory. Report suspicious products to FDA's Office of Criminal Investigations (OCI), as its letter to practices recommends. Report medication-related adverse events, including those involving suspect products, through FDA's MedWatch reporting program.

    Buying Wholesale Supplies Through Portrait's Marketplace

    Use these checks to choose an authorized US source and keep records of what you buy. Portrait's Marketplace gives licensed practices license-verified access to toxins, fillers and other supplies through the authorized US supply chain. Portrait runs its own practices. Seller details, fulfilling company, invoice source and product documentation come with every order. Connect with Portrait to book a demo.

    Frequently Asked Questions About Buying Injectables from Canada

    Does Genuine Product Make a Foreign Purchase Legal?

    No. Ask whether this exact product is authorized and labeled for the US market, not just whether the manufacturer made it. In Kansas, a physician was disciplined even though neither party presented evidence that the product had been adulterated. Genuine origin alone did not prevent enforcement.

    Can I Bring Toxin Back from Canada for My Own Practice?

    No, bringing it back yourself does not turn patient inventory into personal use. FDA draws that boundary around products that will not be sold or distributed further. A small order for your practice still needs a lawful commercial supply path, regardless of who carries it across the border.

    Is a Canadian Pharmacy License Enough for My Supplier?

    No. A Canadian pharmacy license alone does not establish the US authorization required of a prescription-drug supplier. Check the applicable US license or registration, then check the product itself. The supplier's credentials and the shipment's US-market status are separate parts of the buying decision.

    Can the Practitioner Face Consequences Alongside the Practice?

    Yes. The California case reached both: the physician admitted a misdemeanor, while the medical practice admitted a felony. Their pleas concerned unapproved toxins and fillers obtained from sellers outside the United States. Do not assume the supplier or the business alone carries responsibility for what you administer.

    Does the Drug Supply-Chain Law Exempt Foreign Fillers?

    No. Being outside a prescription-drug tracing law does not exempt fillers from device requirements. The California practice case included misbranded and adulterated filler devices, so the distinction is not permission to use them. When checking a filler, focus on the device's US authorization and the supplier.

    Should I Return Suspect Product to the Seller?

    Ask FDA for handling instructions before returning it. In its November 2012 letter, FDA told affected practices to retain and secure products until further notice and not return them at that time. For your inventory, seek current instructions and report any medication-related adverse events through MedWatch.

    Patrick Blake, MD, FAAD

    Medical review

    Patrick Blake, MD, FAAD
    reviewed this article for medical and regulatory accuracy. He is a board-certified dermatologist, Fellow of the American Academy of Dermatology, and co-founder and Chief Medical Officer at Portrait. His training includes Cleveland Clinic Lerner College of Medicine, research at the National Institutes of Health as a Howard Hughes Medical Institute research scholar, and dermatology residency at UT Southwestern.

    Keep reading

    Buying supplies

    How to Spot Fake Botox: A Practice Owner's Guide

    Use supply-path, packaging, and receiving-record checks to spot counterfeit or gray-market injectables before they enter your practice inventory.

    Compliance & regulation

    Who Can Buy Botox? Licensing Guide for Practices

    Separate purchasing authority from permission to inject, learn which credentials suppliers check, and account for state rules before ordering.

    Buying supplies

    Botox Wholesale: How Licensed Practices Buy

    Learn who can buy Botox for a practice, how to check authorized channels and suppliers, and how to avoid counterfeit or gray-market supply.

    One platform

    Everything you need to run your practice

    Portrait combines the technology and support to run and grow an independent medical wellness practice.

    Book Demo